Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D’Angio G et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol Off J Am Soc Clin Oncol 6:1874–1881
Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol Off J Am Soc Clin Oncol 11:1466–1477
McCarville MB (2011) Imaging neuroblastoma: what the radiologist needs to know. Cancer Imaging 11(1A):S44-47
Article PubMed PubMed Central Google Scholar
Cohn SL, Pearson ADJ, London WB, Monclair T, Ambros PF, Brodeur GM et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27:289–297
Article PubMed PubMed Central Google Scholar
Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27:298–303
Article PubMed PubMed Central Google Scholar
Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM et al (2021) Revised neuroblastoma risk classification system: a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 39:3229–3241
Sarioglu FC, Salman M, Guleryuz H, Ozer E, Cecen E, Ince D et al (2019) Radiological staging in neuroblastoma: computed tomography or magnetic resonance imaging? Pol J Radiol 84:e46-53
Article PubMed PubMed Central Google Scholar
Chen AM, Trout AT, Towbin AJ (2018) A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatr Radiol 48:1337–1347
Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261:243–257
Morin CE, Hasweh R, Anton C, Dillman JR, Orscheln E, Smith EA et al (2024) Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis. Pediatr Blood Cancer 71:e30724
Article CAS PubMed Google Scholar
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Article CAS PubMed Google Scholar
Schoen JH, Burdette JH, West TG, Geer CP, Lipford ME, Sachs JR (2024) Savings in CT net scan energy consumption: assessment using dose report metrics and comparison with savings in idle state energy consumption. Am J Roentgenol 222:e2330189
Sung KW, Yoo KH, Koo HH, Kim JY, Cho EJ, Seo YL et al (2009) Neuroblastoma originating from extra-abdominal sites: association with favorable clinical and biological features. J Korean Med Sci 24:461–467
Article PubMed PubMed Central Google Scholar
Kohler JA, Rubie H, Castel V, Beiske K, Holmes K, Gambini C et al (1990) (2013) Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer Oxf Engl 49:3671–3679
Delval A, Touitou T, Gondry-Jouet C, Khanfar C, Haraux E (2024) A non-inferiority study of MRI versus CT for staging and image-defined risk factor assessment in the preoperative work-up of abdominopelvic neuroblastoma. Eur J Radiol 177:111580
Burnand K, Barone G, McHugh K, Cross K (2019) Preoperative computed tomography scanning for abdominal neuroblastomas is superior to magnetic resonance imaging for safe surgical planning. Pediatr Blood Cancer 66:e27955
Parhar D, Joharifard S, Lo AC, Schlosser MP, Daodu OO (2020) How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis. Pediatr Surg Int 36:897–907
Mehta K, Haller JO, Legasto AC (2003) Imaging neuroblastoma in children. Crit Rev Comput Tomogr 44:47–61
Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F (2008) Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer 50:965–969
Macdonald IR, Farhat Z, Amoako-Tuffor Y, Maianski I, Erker C, Romao R et al (2024) MR imaging of pediatric neuroblastoma: is gadolinium enhancement necessary for evaluation of image-defined-risk factors? Can Assoc Radiol J J Assoc Can Radiol 75:404–411
留言 (0)